Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - tolterodine tartrate, quantity: 1 mg - tablet, film coated - excipient ingredients: stearic acid; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; magnesium stearate; hypromellose; sodium starch glycollate; titanium dioxide - detrusitol is indicated for the treatment of patients with overactive bladder with symptoms of urinary frequency, urgency or incontinence or any combination of these symptoms.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; macrogol 6000; titanium dioxide; lactose monohydrate; sodium starch glycollate; hypromellose; povidone; purified talc; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; purified talc; titanium dioxide; sodium starch glycollate; hypromellose; iron oxide yellow; lactose monohydrate; macrogol 6000; maize starch; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; purified talc; titanium dioxide; sodium starch glycollate; hypromellose; iron oxide yellow; lactose monohydrate; macrogol 6000; maize starch; purified water; ethylcellulose; sodium lauryl sulfate; cetyl alcohol; hydrogen peroxide; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; macrogol 6000; titanium dioxide; lactose monohydrate; sodium starch glycollate; hypromellose; povidone; purified talc; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amoxicillin trihydrate, quantity: 1006.25 mg; potassium clavulanate, quantity: 148.875 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; propylene glycol; croscarmellose sodium; ethylcellulose; purified talc; isopropyl alcohol; magnesium stearate; hypromellose; dichloromethane; titanium dioxide; hyprolose; industrial methylated spirit - alphaclav duo forte viatris 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (uncomplicated and complicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infection,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate.,the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets should not require the addition of another antibiotic due to the amoxicillin content of these products.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for the temporary relief of acute moderate pain and inflammation

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; sodium stearylfumarate; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide - movox (fluvoxamine maleate) is indicated for the treatment of major depression in adults. movox (fluvoxamine maleate) is also indicated for the treatment of obsessive compulsive disorder (ocd) in both children aged 8 years and older, adolescent, and adults.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide; sodium stearylfumarate - movox (fluvoxamine maleate) is indicated for the treatment of major depression in adults. movox (fluvoxamine maleate) is also indicated for the treatment of obsessive compulsive disorder (ocd) in both children aged 8 years and older, adolescent, and adults.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: pregelatinised potato starch; titanium dioxide; mannitol; maize starch; macrogol 6000; sodium stearylfumarate; purified talc; hypromellose; colloidal anhydrous silica - luvox (fluvoxamine maleate) is indicated for the treatment of: major depression in adults. it is also indicated for the treatment of obsessive compulsive disorder (ocd) in children aged 8 years of age and older, adolescents and adults.